PTN

NASDAQ HEALTHCARE

Palatin Technologies, Inc. Common Stock

$9.33

$0.27 (+2.98%)

Live quote

52w: $5.61 – $31.00

Loading chart…

P/E Ratio—

P/B Ratio2.49

EV/EBITDA—

Debt/Equity—

ROE-125.30%

ROIC—

Revenue Growth—

Gross Margin—

Palatin Technologies, Inc., a specialty biopharmaceutical company, develops targeted receptor-specific therapies for the treatment of various diseases in the United States. The company is headquartered in Cranbury, New Jersey.

Own PTN? Track it here.

Create a free account to add PTN to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account